ERYTECH PHARMA launches a subscription of BSPCE warrants reserved for its main executives admERY January 28, 2014 Newsroom ERYTECH launch a subscription of BSPCE reserved for its main executives. You Might Also Like ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML December 8, 2017 ERYTECH announces its financial calendar for 2015 January 15, 2015 ERYTECH provides business update and financial results for the full year 2013 April 29, 2014
ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML December 8, 2017
